Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Rangering i aksjer #40617
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Aksjekurs
$1.06
Sist synkronisert: 2021-06-25
Markedsverdi
$110.93K
Endring (1 dag)
-5.36%
Endring (1 år)
0.00%
Land
US
Handel Millendo Therapeutics, Inc. (MLND)

Kategori

EPS for Millendo Therapeutics, Inc. (MLND)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Millendo Therapeutics, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Millendo Therapeutics, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter